Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tocilizumab for Relapsing Polychondritis

This study has been withdrawn prior to enrollment.
(Tocilizumab was licenced in Canada for children, so the study was not necessary)
Sponsor:
Information provided by (Responsible Party):
Dr Maggie Larche, McMaster Children's Hospital
ClinicalTrials.gov Identifier:
NCT01104480
First received: April 13, 2010
Last updated: May 12, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2012
  Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)